Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
U.S. District Judge Robert E. Wier tossed a hemp farm’s $9-million contract dispute suit against
Continue Reading CBD and Hemp Legal and Regulatory Roundup – June 25, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
A Calif.-based hemp products merchant renewed its push for sanctions against a Fla. company
Continue Reading CBD and Hemp Legal and Regulatory Roundup – June 11, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
Charlotte’s Web told a federal judge that Rasunae Moqeet’s proposed class action over the company’s product
Continue Reading CBD and Hemp Legal and Regulatory Roundup – June 4, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
Under the Hemp Access and Consumer Safety Act introduced by Sens. Ron Wyden (D-Ore.), Jeff Merkley (D-Ore.) and Rand Paul
Continue Reading CBD and Hemp Legal and Regulatory Roundup – May 28, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
U.S. District Judge Otis D. Wright II dismissed a proposed class
Continue Reading CBD and Hemp Legal and Regulatory Roundup – May 21, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
The CBD industry faced difficulties in 2020 amid competition, regulatory uncertainty and a global pandemic that disrupted retail operations, including:
Continue Reading CBD and Hemp Legal and Regulatory Roundup – May 7, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
A study explored the pain-reducing effects of CBD as well as the
Continue Reading CBD and Hemp Legal and Regulatory Roundup – April 30, 2021
On Monday, FDA announced two warning letters issued to makers of topical CBD products labeled as OTC drugs. Amidst a backdrop of facility inspections that revealed significant good manufacturing compliance concerns, the most important takeaways in this round of CBD
Continue Reading FDA Enforcement: There’s Nothing Inactive About CBD and “FDA Registered” Is Misleading
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
After seven months of clinical investigation, Validcare’s investigators met with members of the
Continue Reading CBD and Hemp Legal and Regulatory Roundup – March 26, 2021
Welcome to our weekly roundup of CBD and hemp-related legal and regulatory news:
With a wide array of CBD
Continue Reading CBD and Hemp Legal and Regulatory Roundup – March 19, 2021
